journal article·2017-12

Enhancing Therapeutic Efficacy of Combined Cancer Phototherapy by Ultrasound‐Mediated In Situ Conversion of Near‐Infrared Cyanine/Porphyrin Microbubbles into Nanoparticles

Yunxue Xu, Xiaolong Liang, Pravin Bhattarai, Yang Sun, Yiming Zhou, Shumin Wang, Wen Chen, Huiyu Ge, Jinrui Wang, Ligang Cui, Zhifei Dai

Advanced Functional Materials· Volume 27· Issue 48
Publisher page

Abstract

Abstract Nanoparticles (NPs)‐based diagnosis and phototherapy are emerging as the cutting‐edge technologies for detection and treatment of cancer but their applications are still limited since insufficient and heterogeneous NPs accumulation in cancer often causes recurrence. To overcome these limitations, multifunctional microbubbles (MBs) were constructed with 1, 1‐dioctadecyl‐3, 3, 3, 3‐tetramethylindotricarbocyanine iodide (DiR) and porphyrin grafted lipid (PGL). Both DiR and PGL self‐assembled as microbubbles, the as‐designed PGL‐DiR MBs possess remarkably high drug loading contents (5.8% PGL and 10.38% DiR) and stable co‐delivery drug combinations. In vivo experiments showed PGL‐DiR MBs could serve as an excellent ultrasound contrast agent to enhance ultrasound imaging greatly for identifying the location and size of the tumors. Upon exposure to ultrasound, in situ conversion of PGL‐DiR MBs into nanoparticles resulted in a remarkable increase in fluorescence intensity (~5 folds) in tumor compared with PGL‐DiR NPs, validating the enhanced tumor accumulation and cellular uptake of therapeutic agents. PGL‐DiR MBs showed complete tumor ablation without recurrence in vivo, while PGL‐DiR NPs showed only 72.6% tumor growth inhibition at the same dose. We believe that PGL‐DiR MBs will soon reach their full potential as an important class of phototherapeutic formulations and will contribute to remarkable advances in cancer treatments.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Ultrasound and Hyperthermia Applications · Photoacoustic and Ultrasonic Imaging · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Biomedical Engineering College of Engineering Peking University Beijing 100871 China

Department of Ultrasound Peking University Third Hospital Beijing 100191 China

Funding

National Natural Science Foundation of China · Peking University

References (49)

Show source-provided references
1. 10.1007/BF0165520910.1007/BF01655209 ↗
2. 10.1016/j.jphotochemrev.2012.09.00410.1016/j.jphotochemrev.2012.09.004 ↗
3. 10.1007/s10103-007-0470-x10.1007/s10103-007-0470-x ↗
4. 10.1016/j.biomaterials.2011.12.05210.1016/j.biomaterials.2011.12.052 ↗
5. 10.1016/j.canlet.2004.02.00410.1016/j.canlet.2004.02.004 ↗
6. 10.4155/tde.11.7210.4155/tde.11.72 ↗
7. 10.1038/nrc107110.1038/nrc1071 ↗
8. 10.1021/cr900300p10.1021/cr900300p ↗
9. 10.1111/j.1751-1097.1992.tb04222.x10.1111/j.1751-1097.1992.tb04222.x ↗
10. 10.1016/j.jphotobiol.2009.04.00110.1016/j.jphotobiol.2009.04.001 ↗
11. 10.1016/j.biomaterials.2014.02.01110.1016/j.biomaterials.2014.02.011 ↗
12. 10.1002/smll.20140226910.1002/smll.201402269 ↗
13. 10.1039/C5NR90077H10.1039/C5NR90077H ↗
14. 10.1021/nn300694v10.1021/nn300694v ↗
15. 10.1021/nn506687t10.1021/nn506687t ↗
16. 10.1002/adfm.20140145110.1002/adfm.201401451 ↗
17. 10.1016/j.addr.2003.07.01410.1016/j.addr.2003.07.014 ↗
18. Shirasu N. · Anticancer Res. · 2013 · 33 · 2823
19. 10.1517/1742524080244467310.1517/17425240802444673 ↗
20. 10.1007/s12010-011-9383-z10.1007/s12010-011-9383-z ↗
21. 10.1039/c3nr00541k10.1039/c3nr00541k ↗
22. 10.1016/j.biomaterials.2013.03.02710.1016/j.biomaterials.2013.03.027 ↗
23. 10.1016/j.juro.2009.06.03510.1016/j.juro.2009.06.035 ↗
24. 10.1148/radiol.236204110510.1148/radiol.2362041105 ↗
25. 10.1146/annurev.bioeng.8.061505.09585210.1146/annurev.bioeng.8.061505.095852 ↗
26. 10.1016/j.addr.2008.03.00510.1016/j.addr.2008.03.005 ↗
27. 10.1097/01.rli.0000199292.88189.0f10.1097/01.rli.0000199292.88189.0f ↗
28. 10.1186/1476-7120-2-2310.1186/1476-7120-2-23 ↗
29. 10.1039/c0sm01131b10.1039/c0sm01131b ↗
30. Gill S. L. · Technol. Health Care · 2014 · 22 · 3710.3233/THC-130772 ↗
31. 10.1016/j.jconrel.2010.07.11510.1016/j.jconrel.2010.07.115 ↗
32. 10.1016/j.jconrel.2012.12.02510.1016/j.jconrel.2012.12.025 ↗
33. 10.7150/thno.994510.7150/thno.9945 ↗
34. 10.1002/anie.20110355710.1002/anie.201103557 ↗
35. 10.1002/adfm.20160338110.1002/adfm.201603381 ↗
36. 10.1002/adfm.20150489910.1002/adfm.201504899 ↗
37. 10.1016/j.jconrel.2016.07.00510.1016/j.jconrel.2016.07.005 ↗
38. 10.1016/j.colsurfb.2016.10.04210.1016/j.colsurfb.2016.10.042 ↗
39. 10.1002/smll.20160229310.1002/smll.201602293 ↗
40. 10.1016/j.biomaterials.2015.11.05810.1016/j.biomaterials.2015.11.058 ↗
41. 10.1021/acsbiomaterials.6b0029010.1021/acsbiomaterials.6b00290 ↗
42. 10.1039/C5NJ00122F10.1039/C5NJ00122F ↗
43. 10.1021/jacs.6b1138210.1021/jacs.6b11382 ↗
44. 10.1021/acsami.5b0785610.1021/acsami.5b07856 ↗
45. 10.1002/ange.20100828610.1002/ange.201008286 ↗
46. 10.1007/s10895-012-1114-510.1007/s10895-012-1114-5 ↗
47. 10.1038/nnano.2015.2510.1038/nnano.2015.25 ↗
48. 10.1093/jnci/djm04310.1093/jnci/djm043 ↗
49. 10.1016/j.jcis.2008.09.06610.1016/j.jcis.2008.09.066 ↗